- Home
- CNH vs EXEL Comparison
CNH vs EXEL Comparison
Compare CNH & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNH
- EXEL
- Stock Information
- Founded
- CNH 1842
- EXEL 1994
- Country
- CNH United Kingdom
- EXEL United States
- Employees
- CNH N/A
- EXEL N/A
- Industry
- CNH Construction/Ag Equipment/Trucks
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNH Industrials
- EXEL Health Care
- Exchange
- CNH Nasdaq
- EXEL Nasdaq
- Market Cap
- CNH 12.9B
- EXEL 12.0B
- IPO Year
- CNH N/A
- EXEL 2000
- Fundamental
- Price
- CNH $13.39
- EXEL $45.40
- Analyst Decision
- CNH Buy
- EXEL Buy
- Analyst Count
- CNH 11
- EXEL 18
- Target Price
- CNH $14.77
- EXEL $44.29
- AVG Volume (30 Days)
- CNH 22.9M
- EXEL 2.7M
- Earning Date
- CNH 08-01-2025
- EXEL 07-28-2025
- Dividend Yield
- CNH 1.87%
- EXEL N/A
- EPS Growth
- CNH N/A
- EXEL 237.58
- EPS
- CNH 0.80
- EXEL 2.20
- Revenue
- CNH $18,846,000,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- CNH N/A
- EXEL $9.93
- Revenue Next Year
- CNH $6.04
- EXEL $13.17
- P/E Ratio
- CNH $16.73
- EXEL $20.60
- Revenue Growth
- CNH N/A
- EXEL 24.49
- 52 Week Low
- CNH $9.28
- EXEL $22.20
- 52 Week High
- CNH $14.27
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- CNH 55.32
- EXEL 57.52
- Support Level
- CNH $12.63
- EXEL $43.86
- Resistance Level
- CNH $13.14
- EXEL $45.52
- Average True Range (ATR)
- CNH 0.34
- EXEL 1.44
- MACD
- CNH -0.05
- EXEL -0.07
- Stochastic Oscillator
- CNH 46.04
- EXEL 39.60
About CNH CNH Industrial N.V.
CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.